Enochian BioSciences (ENOB) Competitor Comparison
We are evaluating the key criteria listed to compare Enochian BioSciences (ENOB) against its competitors in the Biotechnology industry.
Market Capitalization
312 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
88 / 337Free Cashflow
73 / 352Quick Ratio
350 / 357Earnings per Share
233 / 359Dividend yield
0 / 6Total Cash
340 / 358Performance 3 years
116 / 368Performance 5 years
154 / 368Performance 10 years
137 / 368Linearity 3 years
28 / 368Linearity 5 years
103 / 368Linearity 10 years
77 / 367Total Rank
116 / 368Dividend Rank
119 / 368Valuation Rank
302 / 368Piotroski Rank
231 / 368Muliplier Rank
338 / 368Market Capitalization - ENOB ranking 312 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.